FDA inspection
Anderson Compounding Pharmacy, Inc.: FDA inspection ending Apr 5, 2019
FDA inspection 1085801 · Official Action Indicated (OAI) · Bristol, TN
Key facts
| Inspection ID | 1085801 |
|---|---|
| Firm | Anderson Compounding Pharmacy, Inc. |
| FEI number | 3014877770 |
| Address | Attn: Cleve Anderson, 310 Bluff City Hwy |
| City | Bristol |
| State | TN |
| ZIP | 37620 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Apr 5, 2019 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 598303 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data